The CRIS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CRIS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CRIS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CRIS Detailed Price Forecast - CNN Money||View CRIS Detailed Summary - Google Finance|
|View CRIS Detailed Summary - Yahoo! Finance||View CRIS Stock Research & Analysis - Zacks.com|
|View CRIS Trends & Analysis - Trade-Ideas||View CRIS Major Holders - Barrons|
|View CRIS Call Transcripts - NASDAQ||View CRIS Breaking News & Analysis - Seeking Alpha|
|View CRIS Annual Report - CompanySpotlight.com||View CRIS OTC Short Report - OTCShortReport.com|
|View CRIS Fundamentals - TradeKing||View CRIS SEC Filings - Bar Chart|
|View Historical Prices for CRIS - The WSJ||View Performance/Total Return for CRIS - Morningstar|
|View the Analyst Estimates for CRIS - MarketWatch||View the Earnings History for CRIS - CNBC|
|View the CRIS Earnings - StockMarketWatch||View CRIS Buy or Sell Recommendations - MacroAxis|
|View the CRIS Bullish Patterns - American Bulls||View CRIS Short Pain Metrics - ShortPainBot.com|
|View CRIS Stock Mentions - StockTwits||View CRIS Stock Mentions - PennyStockTweets|
|View CRIS Stock Mentions - Twitter||View CRIS Investment Forum News - Investor Hub|
|View CRIS Stock Mentions - Yahoo! Message Board||View CRIS Stock Mentions - Seeking Alpha|
|View Insider Transactions for CRIS - SECform4.com||View Insider Transactions for CRIS - Insider Cow|
|View CRIS Major Holdings Summary - CNBC||View Insider Disclosure for CRIS - OTC Markets|
|View Insider Transactions for CRIS - Yahoo! Finance||View Institutional Holdings for CRIS - NASDAQ|
|View CRIS Stock Insight & Charts - FinViz.com||View CRIS Investment Charts - StockCharts.com|
|View CRIS Stock Overview & Charts - BarChart||View CRIS User Generated Charts - Trading View|
Curis Announces Presentation at Cowen & Company 39th Annual Healthcare Conference
Posted on Monday March 04, 2019
LEXINGTON, Mass. , March 4, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced ...
Curis, Inc. to Present at the 2019 BIO CEO & Investor Conference
Posted on Monday February 04, 2019
LEXINGTON, Mass. , Feb. 4, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced ...
Has Curis (CRIS) Outpaced Other Medical Stocks This Year?
Posted on Tuesday January 29, 2019
Is (CRIS) Outperforming Other Medical Stocks This Year?
First Mesothelioma Patient Dosed in CA-170 Study
Posted on Thursday January 24, 2019
LEXINGTON, Mass., Jan. 24, 2019 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the first mesothelioma patient has been enrolled and dosed in the Phase I study of CA-170. CA-170 is an orally available, dual inhibitor of VISTA and PDL1, which the company believes could provide benefit in tumors with high levels of VISTA expression. The company had previously announced its expectation to begin enrollment of mesothelioma patients in a dedicated cohort within the existing Phase 1 study.